• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Holdings
© 2025 Longbridge|Disclaimer

Schedules & Filings

Schedules
Filings
Dec18
Distribution Plan(EST)

Cash dividend 0.1836 USD

Dec17
Distribution Plan(EST)

Cash dividend 0.1836 USD

Distribution Plan(EST)

Cash dividend 0.1836 USD

View More

Event Tracking

Dec11
Zentelxin (Cumbexil) Approved for Market by Chong Kun Dang Pharmaceutical
10:29
Hanson Pharmaceutical Group Reports Strong Phase II Clinical Trial Results for RET Inhibitor Resencatinib
10:09
Dec10
Stone Pharmaceutical Group Secures FDA Approval for Weight Management Drug Trial
11:48
Sage Pharmaceutical Obtains Approval from FDA and NMPA to Initiate Clinical Trials for Act RIIA/IIB Monoclonal Antibody
10:18
Hanson Pharmaceutical's risvutatug rezetecan shows promising results in Phase 1 trial for NSCLC
09:54
Guoyuan International Gives SinoPharm Group a 'Buy' Rating, Optimistic About Innovative Drug R&D and Internationalization Strategy
03:51